{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:16:04Z","timestamp":1760242564395,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Podiatric Medicine and Surgery"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.cpm.2004.05.002","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T10:53:30Z","timestamp":1113821610000},"page":"591-604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The oral antifungal patient"],"prefix":"10.1016","volume":"21","author":[{"given":"Warren S.","family":"Joseph","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5 Pt 1","key":"10.1016\/j.cpm.2004.05.002_BIB1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0190-9622(98)70199-9","article-title":"Effect of onychomycosis on quality of life","volume":"38","author":"Drake","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.cpm.2004.05.002_BIB2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1046\/j.1365-4362.1997.00163.x","article-title":"The effect of toenail onychomycosis on patient quality of life","volume":"36","author":"Elewski","year":"1997","journal-title":"Int J Dermatol"},{"issue":"1\u20132","key":"10.1016\/j.cpm.2004.05.002_BIB3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1026429012353","article-title":"A health-related quality of life measure for use in patients with onychomycosis: a validation study","volume":"8","author":"Lubeck","year":"1999","journal-title":"Qual Life Res"},{"issue":"6 Pt 2","key":"10.1016\/j.cpm.2004.05.002_BIB4","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0190-9622(98)70490-6","article-title":"Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail","volume":"38","author":"Scher","year":"1998","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.cpm.2004.05.002_BIB5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/archderm.1996.03890250044008","article-title":"Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole","volume":"132","author":"De Doncker","year":"1996","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.cpm.2004.05.002_BIB6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.7547\/87507315-93-5-373","article-title":"Satisfaction with onychomycosis treatment. Pulse versus continuous dosing","volume":"93","author":"Warshaw","year":"2003","journal-title":"J Am Podiatr Med Assoc"},{"issue":"7190","key":"10.1016\/j.cpm.2004.05.002_BIB7","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/bmj.318.7190.1031","article-title":"Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group","volume":"318","author":"Evans","year":"1999","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.cpm.2004.05.002_BIB8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1067\/mjd.2000.107754","article-title":"A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns","volume":"43","author":"Ghannoum","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.cpm.2004.05.002_BIB9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1067\/S0190-9622(03)01480-4","article-title":"Comparison of diagnostic methods in the evaluation of onychomycosis","volume":"49","author":"Weinberg","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.cpm.2004.05.002_BIB10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1046\/j.1365-4362.1997.00349.x","article-title":"Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada\u2014a multicenter survey of 2001 patients","volume":"36","author":"Gupta","year":"1997","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.cpm.2004.05.002_BIB11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1046\/j.1365-2133.2002.04639.x","article-title":"Long-term results in patients with onychomycosis treated with terbinafine or itraconazole","volume":"146","author":"Heikkila","year":"2002","journal-title":"Br J Dermatol"}],"container-title":["Clinics in Podiatric Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891842204000436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891842204000436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:49:39Z","timestamp":1760208579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891842204000436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0891842204000436"],"URL":"https:\/\/doi.org\/10.1016\/j.cpm.2004.05.002","relation":{},"ISSN":["0891-8422"],"issn-type":[{"type":"print","value":"0891-8422"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The oral antifungal patient","name":"articletitle","label":"Article Title"},{"value":"Clinics in Podiatric Medicine and Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpm.2004.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}